01 — At a Glance
India’s Most Expensive Hospital. The Stock Too.
- 52-Week High / Low₹1,314 / ₹934
- Q3 FY26 Revenue₹2,068 Cr
- Q3 FY26 PAT (reported)₹301 Cr
- Q3 FY26 EPS₹3.09
- TTM EPS₹14.59
- Book Value₹103
- Price to Book10.1x
- Debt / Equity0.33x
- Occupancy (Q3 FY26)74%
- ARPOB (Q3 FY26)₹77,900
One-Line Verdict: Max Healthcare delivered 21 consecutive quarters of YoY growth, posted ₹2,068 Cr quarterly revenue (+10.7% YoY), but PAT took a -17.2% QoQ hit due to an exceptional item (Code on Wages + merger stamp duty), a CGHS chemo-drug pricing fiasco, and management’s candid admission of “excessive unanticipated seasonal softness.” The 3-month return sits at -5.05%. The market cap still calmly idles at ₹1.01 lakh crore. These two facts need a mediator.
02 — Introduction
Premium Hospitals. Premium Margins. Premium Valuation. Premium Headaches.
Welcome to Max Healthcare — India’s largest hospital chain by market cap, second largest by revenue and EBITDA, and quite possibly the only company that can blame a dengue season for a bad quarter and have analysts nod approvingly on the concall.
The Delhi-NCR powerhouse operates 22 hospitals and medical centres across North India with a network of ~5,200 beds. It performs 14,800 oncology surgeries and ~48,000 cardiac procedures a year. It partners with Boston University, Imperial College London, and IIT Bombay on research. It has 3,000 published research papers. And somehow, it still found itself in a bureaucratic tiff with the government over chemotherapy drug pricing at ₹70 when its purchase cost was ₹80. Government math is special.
Q3 FY26 (Oct–Dec 2025) was the 21st consecutive quarter of year-on-year growth. But growth quality took a hit — a temporary shift toward lower-margin institutional patients, GST rate changes, pre-commissioning expenses, and a vector-borne disease season so bad (or good, depending on your bed occupancy preferences) that management specifically said rains continued into winter and there was “really no stagnation of water.” So no dengue. No dengue means fewer emergency admissions. Welcome to a business where clear skies hurt your P&L.
Concall Gem (Feb 2026): Management on the seasonal miss — “excessive unanticipated seasonal softness.” Twelve words that explain a ₹253 Cr QoQ PAT drop without once blaming the company. Respect the craft.
03 — Business Model: WTF Do They Even Do?
They Fix You. Then Bill You. Repeat 5,200 Times a Day.
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
